Gynecologic Oncology Fellowship
The gynecologic oncology fellowship at the University of Washington (UW) is a four-year program accepting one applicant per year for a maximum of four fellows at any given time. The program has been developed to train gynecologic oncologists who will be leaders in patient care, research, surgical expertise, innovative cancer therapies, and education. We intend to accomplish this by training fellows in the comprehensive management of gynecologic malignancies and research. We believe that strong mentorship is the best way to assure success of our fellows and therefore we will pair them with both research and clinical mentors.
The fellowship is based primarily at the University of Washington Medical Center (UWMC) and Seattle Cancer Care Alliance (SCCA), and includes rotations at Swedish Medical Center (SMC). UWMC is a 450-bed hospital providing tertiary care for the Pacific Northwest region. It is a major clinical resource for high-risk obstetrics, neonatology, gynecologic oncology, urogynecology, assisted reproductive endocrinology, infectious diseases, genetics, and breast cancer.
SCCA is an alliance between UWMC, Fred Hutchinson Cancer Research Center (FHCRC), and Children's Hospital and Regional Medical Center (CHRMC). The SCCA provides comprehensive cancer care for the Northwest region. FHCRC and UWMC are designated as an NCI Comprehensive Cancer Center. As part of this consortium, there is a dedicated gynecologic cancer research program.
The division of gynecologic oncology at UW includes six board certified gynecologic oncologists. Each faculty member is active in clinical and/or laboratory research. While the surgical and clinical experience is exceptional, this program also provides an excellent opportunity for epidemiologic or basic science research. FHCRC has developed a gynecologic cancer research program (GCRP) that brings together researchers with common interests in gynecologic malignancies, provides infrastructure for data collection, tissue banking, and funds for pilot projects. FHCRC, in collaboration with UW and SMC currently has an NIH ovarian cancer SPORE grant, one of only five in the U.S., and is actively conducting research projects in early detection, biomarker development, chemoresistance, and modeling for prediction of cancer. UW is one of the lead sites for HPV vaccine research and cancer genetics. FHCRC actively studies the epidemiology of gynecologic malignancies. For fellows with interests in any of these areas, we have identified mentors who have agreed to participate in the research training.
The UW provides office space, computers, and secretarial, library, medical illustration and graphics support for the fellows.
2017 Application Information
Applications will be accepted through the Electronic Residency Application System (ERAS) website: https://www.aamc.org/students/eras/
NOTE: Applicants must be USA citizens or permanent residents (green card). Due to the nature of fellowship funding, applications from H1B and J1 Visa holders cannot be accepted.
Application deadline is Friday, April 15, 2016 for Fellowships beginning July 2017.
Applications must include:
- Three letters of recommendation
- Letter of good standing from program director
- Current curriculum vitae
- Personal statement
- Official transcript from all medical schools attended
- USMLE transcript, including all attempts
- CREOG scores
- Copy of medical school diploma
- Recent photograph
For further information, please contact:
Department of Obstetrics and Gynecology, Box 356460
University of Washington School of Medicine
Seattle, WA 98195-6460
Gynecologic Oncology Faculty
Barbara Goff, MD
Director, Gynecologic Oncology
||Heidi Gray, MD
Director, Gynecologic Oncology Fellowship
||Benjamin Greer, MD
Medical Director, SCCA Network
||John Liao, MD, PhD
Assistant Professor Professor
||Barbara Norquist, MD
||Kathryn Pennington, MD
||Elizabeth Swisher, MD
Adjunct Professor, Department of Medicine, Division of Medical Genetics
||Hisham Tamimi, MD
Renata Urban, MD
Director, 4th Year Gynecologic Oncology Clerkship
Associate Director, Gynecologic Oncology Fellowship
||Emily Wu, MD
||Jovana Martin, MD
||Tiffany Beck, MD, MPH
||Minh Dao, MD
Education Program & Research Activities
Fellows spend the first two years of their fellowship devoted to research. They choose a research mentor in either basic science or epidemiology and spend most of their time directly in research activities with that mentor, although a portion of their time will be in coursework and seminars directly contributing to their development as a clinician/scientist. Fellows choosing the basic science track will spend 90% of their time in hands-on laboratory work. For those choosing the epidemiology track, a greater portion of time will be spent in coursework, and they will obtain a Masters in Public Health or in Epidemiology at the end of their research years. During this time fellows will have minimal clinical responsibilities; however, in the first year fellows will attend a highrisk breast and ovarian cancer clinic once a month, a multidisciplinary clinic in which a consultation is provided by a team including a gynecologic oncologist, medical oncologist, breast surgeon, and genetics counselor.
Fellows are expected to participate in weekly laboratory group meetings, grand rounds, M&M, tumor boards, and monthly journal club, GCRP, and division research meetings. All fellows will be encouraged to continue some clinical research projects during their clinical years and will be expected to submit abstracts to selected appropriate meetings during their fellowship, including the Society of Gynecologic Oncologists (SGO), the Western Association of Gynecologic Oncologists (WAGO), American Society of Clinical Oncology (ASCO), and American Association of Cancer Research. Each fellow will attend at least one such meeting annually, but will be encouraged to attend diverse meetings over the course of four years. Fellows are also expected to present their thesis project at the Resident and Fellow Research Day at the end of their fellowship.
Research Opportunities, Supervision, and Thesis Guidance
Mentorship is the cornerstone of the planned research experience in our fellowship. We have carefully chosen a varied group of potential mentors for fellows. The faculty are world-renowned scientists in varied areas of gynecologic oncology research. Each of the mentors has supervised many previous graduate students and post-doctoral fellows. Fellows are expected to participate in departmental seminars, laboratory meetings and other educational experiences (research retreats, etc.) that are part of that mentor's training program. Although the mentors are affiliated with a variety of outside departments, they have served as mentors to postdoctoral fellows on our department's Women's Reproductive Health Research (WRHR) training grant since 1999. Thus, these specific mentors already have strong ties to our department and were selected from among many researchers in gynecologic cancers at both UW and FHCRC because of their previous experience successfully training clinical fellows in ob/gyn research.
The current list of research mentors, all of whom have joint appointments at both FHCRC and the UW, includes:
- Mary (Nora) Disis, MD, Professor, Department of Medicine (UW/FHCRC)
- David Flum, MD, MPH, Professor, Departments of Surgery and Public Health (UW)
- Denise Galloway, PhD, Professor, Microbiology (UW)
- Stephen Hawes, MS, PhD, Associate Professor, Epidemiology (UW)
- Mary-Claire King, PhD, Professor, Departments of Medicine & Genome Sciences (UW)
- Christopher Li, MD, PhD, Professor, Epidemiology (UW)
- Mary Ann Rossing,k PhD, DVM, Associate Member, Public Health Sciences (FHCRC)
- Elizabeth Swisher, MD, Professor, Department of Obstetrics and Gynecology (UW)
- Melissa Schiff, MD, MPH, Professor, Departments of Obstetrics and Gynecology and Epidemiology (UW)
- Nicole Urban, PhD, Program Head, Gynecologic Cancer Research Program (FHCRC)
University of Washington/University of Washington Medical Center (UW/UWMC)
Fellows will spend the third and fourth years of the fellowship in clinical care. Inpatient care is facilitated at UWMC, a 450-bed hospital with 25 operating rooms, 10 of which are dedicated to advanced laparoscopy and robotics, and a dedicated gynecologic oncology floor. Surgical oncology will be taught by the gynecologic oncology faculty. When patients enter the system at the UWMC they are assigned to an individual faculty member who then provides continuity of care throughout their experience in our system. This includes both inpatient and outpatient management. Fellows will be supervised and advised by a faculty member at all times, allowing for progressively increasing responsibility and independence. Inpatient ward rounds are typically carried out as a team consisting of medical students, residents, attendings, and the fellows. In addition, pharmacy residents, nutritionists, nursing staff, and social workers will often round with the team to facilitate integrated and comprehensive care of our patients.
Seattle Cancer Care Alliance (SCCA)
Outpatient care and teaching occurs at SCCA, a separate campus approximately two miles from UW and available by convenient shuttle service. There are 12 rooms dedicated to gynecologic oncology each day. Fellows see outpatients in conjunction with a division faculty member approximately two days per week. Although this includes initial consultations, follow-up, postoperative visits, second opinion, pre-chemotherapy visits, and palliative care visits, emphasis will be placed on diagnosis and treatment planning for new patients and second opinions. Chemotherapy is administered in the infusion suite on site. Fellows will be expected to become progressively knowledgeable regarding chemotherapy, and to write chemotherapy orders under supervision of faculty members during years three and four of their clinical fellowship.
Swedish Medical Center (SMC)
During the third and fourth years of fellowship, fellows will have clinical rotations at SMC and will be supervised and advised by faculty members at all times. SMC has three campuses, but the fellows will be primarily at SMC on First Hill, a 600-bed hospital with 48 operating rooms. There is a dedicated floor for gynecologic oncology patients with 20 beds. Fellows will be responsible for rounding with residents each morning and faculty in the afternoon. They will operate with attending gynecologic oncologists three days a week and attend clinic with attendings one and a half days a week.
The gynecologic oncology group at SMC provides both office-based and hospital-based chemotherapy. There are 11 exam rooms and a chemoinfusion facility with 3 chairs and chemotherapy is managed for 45-50 patients on a monthly basis. Fellows will be expected to provide care and write chemotherapy orders with faculty supervision for patients requiring chemotherapy in the office. In addition to providing inpatient care at SMC, fellows will provide outpatient care, including chemotherapy orders, at the outpatient clinic adjacent to the hospital.
At all times fellows will adhere to an 80-hour workweek.